TG Therapeutics’ TGTX shares rose nearly 7% in after-hours trading, following the release of preliminary fourth-quarter and ...

TG Therapeutics, Inc. (NASDAQ: TGTX) shares climbed in Tuesday’s extended trading after the company released its preliminary ...

TG Therapeutics is winding down its oncology program after removing the FDA-approved cancer med Ukoniq from the market in two indications that were granted accelerated approval in addition to ...

Looking ahead, TG Therapeutics provided 2026 revenue guidance of $875-900 million, aligning with analyst consensus of $895.6 million. The company expects BRIUMVI U.S. net product revenue to account ...

TG's revenue is comprised almost entirely of Briumvi sales, so when those sales improve so does the company's revenue line. This amounted to just under $121 million in the biotech company's first ...

The OM System TG-7 is pretty much the same camera as the TG-6, which itself isn't very different than the TG-5. This relative lack of change is an effect of a shrinking compact camera market and ...